Justin Gunn
Equibles does not estimate personal net worth.
About Justin Gunn
Corcept Therapeutics Inc reported in an 8-K filed September 23, 2026 that Justin Gunn was appointed President, Endocrinology, effective October 1, 2026. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.
“Justin Gunn will succeed Mr. Maduck and will fully assume his new responsibilities starting October 1.”
Affiliation history
-
Corcept Therapeutics Inc (CORT)
SEC 8-K
Current2026-10-01–present
Company network
Leadership on record at Corcept Therapeutics Inc
- Joseph K. Belanoff CEO, Board Member
- James N. Wilson Chairman, Board Member
- Atabak Mokari CFO
- Joshua M. Murray CFO, Head of Investor Relations, Board Member
- Daniel N. Swisher COO
- J.D. Lyon Chief Accounting Officer
- Joseph D. Lyon Chief Accounting Officer
- Daniel N. Swisher, Jr. Board Member
- David L. Mahoney Board Member
- G. Leonard Baker, Jr. Board Member